Celon Pharma S.A. (CLN.WA)

PLN 24.05

(-1.84%)

Gross Profit Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual gross profit in 2023 was 97.57 Million PLN , up 2.22% from previous year.
Celon Pharma S.A.'s latest quarterly gross profit in 2024 Q2 was 36.35 Million PLN , up 311.05% from previous quarter.
Celon Pharma S.A. reported a annual gross profit of 95.45 Million PLN in annual gross profit 2022, down -11.49% from previous year.
Celon Pharma S.A. reported a annual gross profit of 107.84 Million PLN in annual gross profit 2021, up 0.55% from previous year.
Celon Pharma S.A. reported a quarterly gross profit of 36.35 Million PLN for 2024 Q2, up 311.05% from previous quarter.
Celon Pharma S.A. reported a quarterly gross profit of 26.17 Million PLN for 2023 Q3, up 0.42% from previous quarter.

Annual Gross Profit Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Gross Profit of Celon Pharma S.A. (2023 - 2012)

Year	Gross Profit	Gross Profit Growth
2023	97.57 Million PLN	2.22%
2022	95.45 Million PLN	-11.49%
2021	107.84 Million PLN	0.55%
2020	107.25 Million PLN	35.96%
2019	78.89 Million PLN	-18.73%
2018	97.06 Million PLN	17.44%
2017	82.65 Million PLN	-17.58%
2016	100.28 Million PLN	29.38%
2015	77.51 Million PLN	-0.41%
2014	77.83 Million PLN	36.86%
2013	56.87 Million PLN	76.7%
2012	32.18 Million PLN	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	-17.22 Million PLN	-169.9%
2024 Q2	36.35 Million PLN	311.05%
2023 Q3	26.17 Million PLN	0.42%
2023 Q1	22.7 Million PLN	-10.86%
2023 FY	97.57 Million PLN	2.22%
2023 Q2	26.06 Million PLN	14.8%
2023 Q4	24.64 Million PLN	-5.83%
2022 Q2	26.25 Million PLN	31.62%
2022 Q1	19.95 Million PLN	3.02%
2022 FY	95.45 Million PLN	-11.49%
2022 Q4	25.46 Million PLN	7.12%
2022 Q3	23.77 Million PLN	-9.46%
2021 Q3	29.08 Million PLN	-8.47%
2021 FY	107.84 Million PLN	0.55%
2021 Q4	19.36 Million PLN	-33.43%
2021 Q1	29.84 Million PLN	3.14%
2021 Q2	31.78 Million PLN	6.48%
2020 Q2	29.65 Million PLN	45.49%
2020 Q1	20.38 Million PLN	-5.49%
2020 Q4	28.93 Million PLN	24.83%
2020 FY	107.25 Million PLN	35.96%
2020 Q3	23.18 Million PLN	-21.83%
2019 Q3	18.39 Million PLN	17.25%
2019 Q1	23.23 Million PLN	-21.21%
2019 Q2	15.69 Million PLN	-32.46%
2019 FY	78.89 Million PLN	-18.73%
2019 Q4	21.56 Million PLN	17.2%
2018 Q3	22.83 Million PLN	-0.94%
2018 Q2	23.05 Million PLN	6.3%
2018 Q1	21.68 Million PLN	-5.31%
2018 Q4	29.48 Million PLN	29.11%
2018 FY	97.06 Million PLN	17.44%
2017 Q4	22.9 Million PLN	33.03%
2017 Q3	17.21 Million PLN	-19.35%
2017 FY	82.65 Million PLN	-17.58%
2017 Q2	21.34 Million PLN	0.8%
2017 Q1	21.18 Million PLN	-49.54%
2016 Q2	23.4 Million PLN	-28.56%
2016 FY	100.28 Million PLN	29.38%
2016 Q4	41.97 Million PLN	176.89%
2016 Q1	32.76 Million PLN	74.1%
2016 Q3	15.16 Million PLN	-35.22%
2015 Q4	18.81 Million PLN	43.09%
2015 FY	77.51 Million PLN	-0.41%
2015 Q3	13.15 Million PLN	0.0%
2014 FY	77.83 Million PLN	36.86%
2013 FY	56.87 Million PLN	76.7%
2012 FY	32.18 Million PLN	0.0%

Peer Gross Profit Comparison of Celon Pharma S.A.

Name	Gross Profit	Gross Profit Difference